{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:22:36Z","timestamp":1783189356782,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network","award":["223131"],"award-info":[{"award-number":["223131"]}]},{"DOI":"10.13039\/501100004963","name":"European Commission Framework 7 Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche Diagnostics GmBH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["33CS30-134277"],"award-info":[{"award-number":["33CS30-134277"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["148522"],"award-info":[{"award-number":["148522"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SHCS research foundation"},{"DOI":"10.13039\/501100000780","name":"European Commission BIOMED 1","doi-asserted-by":"publisher","award":["CT94-1637"],"award-info":[{"award-number":["CT94-1637"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission BIOMED 1","doi-asserted-by":"publisher","award":["CT97-2713"],"award-info":[{"award-number":["CT97-2713"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004966","name":"5th Framework","doi-asserted-by":"publisher","award":["QLK2-2000-00773"],"award-info":[{"award-number":["QLK2-2000-00773"]}],"id":[{"id":"10.13039\/501100004966","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004965","name":"6th Framework","doi-asserted-by":"publisher","award":["LSHP-CT-2006-018632"],"award-info":[{"award-number":["LSHP-CT-2006-018632"]}],"id":[{"id":"10.13039\/501100004965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"7th Framework","doi-asserted-by":"publisher","award":["260694"],"award-info":[{"award-number":["260694"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen R&D","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck and Co. Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["108787"],"award-info":[{"award-number":["108787"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.cmi.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T17:58:25Z","timestamp":1445795905000},"page":"191-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Contribution of APOBEC3G\/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants"],"prefix":"10.1016","volume":"22","author":[{"given":"M.","family":"Noguera-Julian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cozzi-Lepri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Di Giallonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schuurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"D\u00e4umer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ceccherini-Silberstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"D'Arminio Monforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Geretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.L.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Michalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Masquelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bellecave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Kouyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schultze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.F.","family":"G\u00fcnthard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Brun-Vezinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J.","family":"Metzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin J.","family":"Metzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cozzi-Lepri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Schuurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Brun-Vezinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huldrych","family":"G\u00fcnthard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ceccherini-Silberstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Geretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Masquelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2015.10.004_bib1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2011.375","article-title":"Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis","volume":"305","author":"Li","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2015.10.004_bib2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/cid\/ciu287","article-title":"Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive hiv-1 drug resistance testing","volume":"59","author":"Pou","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.10.004_bib3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jac\/dku426","article-title":"Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multi-cohort European case-control study using centralized ultrasensitive 454 sequencing","volume":"70","author":"Cozzi-Lepri","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2015.10.004_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/infdis\/jit310","article-title":"Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection","volume":"208","author":"Metzner","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.10.004_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7824947","article-title":"HIV population dynamics in\u00a0vivo: implications for genetic variation, pathogenesis, and therapy","volume":"267","author":"Coffin","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.cmi.2015.10.004_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein","volume":"418","author":"Sheehy","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2015.10.004_bib7","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.cub.2004.06.057","article-title":"Cytidine deamination of retroviral DNA by diverse APOBEC proteins","volume":"14","author":"Bishop","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.cmi.2015.10.004_bib8","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1093\/nar\/gkq174","article-title":"Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction","volume":"38","author":"Refsland","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cmi.2015.10.004_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nsmb758","article-title":"Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome","volume":"11","author":"Yu","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.cmi.2015.10.004_bib10","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1093\/nar\/gkt246","article-title":"APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure","volume":"41","author":"Holtz","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cmi.2015.10.004_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1742-4690-5-51","article-title":"HIV-1 Vif, APOBEC, and intrinsic immunity","volume":"5","author":"Goila-Gaur","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.cmi.2015.10.004_bib12","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/QAD.0b013e32833e515a","article-title":"Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals","volume":"24","author":"Fourati","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2015.10.004_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4690-6-16","article-title":"APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA","volume":"6","author":"Russell","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.cmi.2015.10.004_bib14","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1073\/pnas.0307132101","article-title":"A\u00a0single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif)","volume":"101","author":"Schr\u00f6felbauer","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2015.10.004_bib15","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.ppat.0010006","article-title":"Natural variation in Vif: differential impact on APOBEC3G\/3F and a potential role in HIV-1 diversification","volume":"1","author":"Simon","year":"2005","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2015.10.004_bib16","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1128\/JVI.02630-09","article-title":"Moderate influence of human APOBEC3F on HIV-1 replication in primary lymphocytes","volume":"84","author":"Mulder","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.10.004_bib17","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1073\/pnas.0710190105","article-title":"Cytidine deamination induced HIV-1 drug resistance","volume":"105","author":"Mulder","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2015.10.004_bib18","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1128\/JVI.00056-10","article-title":"APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis","volume":"84","author":"Sadler","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.10.004_bib19","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/QAD.0b013e3283560703","article-title":"E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure","volume":"26","author":"Fourati","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2015.10.004_bib20","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1128\/JVI.00554-08","article-title":"Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants","volume":"82","author":"Knoepfel","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.10.004_bib21","doi-asserted-by":"crossref","first-page":"e90581","DOI":"10.1371\/journal.pone.0090581","article-title":"MOSAIK: a Hash-Based Algorithm for Accurate Next-Generation Sequencing Short-Read Mapping","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.10.004_bib22","series-title":"R: a Language and Environment for Statistical Computing","author":"Team","year":"2013"},{"key":"10.1016\/j.cmi.2015.10.004_bib23","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cmi.2015.10.004_bib24","first-page":"99","article-title":"Nomenclature for incompletely specified bases in nucleic acid sequences. Recommendations 1984","volume":"3","author":"Nomenclature Committee for the International Union of Biochemistry (NC-IUB)","year":"1986","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.cmi.2015.10.004_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-4690-9-92","article-title":"The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus","volume":"9","author":"van der Kuyl","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.cmi.2015.10.004_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/QAD.0000000000000182","article-title":"Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartments","volume":"28","author":"Fourati","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2015.10.004_bib27","doi-asserted-by":"crossref","first-page":"e1000367","DOI":"10.1371\/journal.ppat.1000367","article-title":"Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance","volume":"5","author":"Jern","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2015.10.004_bib28","doi-asserted-by":"crossref","first-page":"10402","DOI":"10.1128\/JVI.01223-10","article-title":"Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure","volume":"84","author":"Kim","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.10.004_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jviromet.2010.11.016","article-title":"In-depth analysis of G-to-A hypermutation rate in HIV-1 env DNA induced by endogenous APOBEC3 proteins using massively parallel sequencing","volume":"171","author":"Knoepfel","year":"2011","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.cmi.2015.10.004_bib30","doi-asserted-by":"crossref","first-page":"12882","DOI":"10.1128\/JVI.01460-14","article-title":"Possible footprints of APOBEC3F and\/or other APOBEC3 deaminases - but not APOBEC3G - on HIV-1 from patients during acute\/early and chronic infection","volume":"88","author":"Armitage","year":"2014","journal-title":"J\u00a0Virol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15009039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15009039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T09:10:16Z","timestamp":1668762616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15009039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1198743X15009039"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2015.10.004","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of APOBEC3G\/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}